Last reviewed · How we verify
NCT02934854: BioCDS
Biomarker for Creatine Deficiency Syndromes (BioCDS)
trial in Intellectual Disability. Withdrawn.
28 February 2021
Quick facts
| Lead sponsor | CENTOGENE GmbH Rostock |
|---|---|
| Status | Withdrawn |
| Study type | OBSERVATIONAL |
| Start date | 20 August 2018 |
| Primary completion | 28 February 2021 |
| Estimated completion | 28 February 2021 |
| Sites | 4 locations across Sri Lanka, Egypt, India |
Conditions studied
- Intellectual Disability — all drugs for Intellectual Disability →
- Developmental Delay — all drugs for Developmental Delay →
- Movement Disorder — all drugs for Movement Disorder →
- Behavioral Disorder — all drugs for Behavioral Disorder →
Sponsor
CENTOGENE GmbH Rostock
Who can join
2 Months and older, any sex, with Intellectual Disability or Developmental Delay. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Development of a new mass spectrometry-based biomarker for the ear-ly and sensitive diagnosis of the Creatine Deficiency Syndromes from dry-blood-spot sample
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT02934854
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Intellectual Disability
Currently open trials in the same condition.
- NCT05473429 — Characterization of Nociception Phenotype in Individuals With Intellectual Disability · NA · recruiting
- NCT07497035 — Equine Therapy Programme on Stress, Autonomy and Balance in School-age Children With Intellectual Disabilities · NA · active not recruiting
- NCT07059858 — Bladder and Bowel Functions, Participation and Quality of Life in Children With Intellectual Disabilities · recruiting
- NCT07278544 — Harnessing Communication Preferences · NA · recruiting
- NCT06829264 — Testing an Evidence-Based Supported Employment Model in Autistic Young Adults · NA · recruiting
Other CENTOGENE GmbH Rostock trials
Trials by the same sponsor.
- NCT06040008 — Investigating the Impact of Environmental Factors on the Transcriptomics Profile in Healthy Individuals · completed
- NCT05075187 — Epidemiological Study in FRONtoTemporal Dementia · completed
- NCT04925804 — Unraveling Genetics of HypoPhosPhatasia (HPP Genetics) · completed
- NCT04548921 — Biomarker for Friedreich's Ataxia (BioFridA) · unknown
- NCT03866590 — Pyruvate Kinase Deficiency Epidemiological Study (PIECE) · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02934854 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by CENTOGENE GmbH Rostock
- Last refreshed: 13 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02934854.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing